Abstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignancies in humans worldwide with few therapeutic options. Curative therapy remains a major challenge. Here, we demonstrate the therapeutic potential of a novel oncolytic vaccinia virus against human PDAC cells.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
